GF Fund Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$529K Sell
14,674
-6,549
-31% -$220K 0.01% 211
2026
Q1
$762K Buy
21,223
+2,579
+14% +$66.8K 0.01% 202
2025
Q4
$370K Sell
18,644
-155
-0.8% -$2.98K 0.01% 242
2025
Q3
$343K Sell
18,799
-1,496
-7% -$24.6K 0.01% 240
2025
Q2
$320K Buy
20,295
+305
+2% +$3.88K 0.01% 286
2025
Q1
$253K Sell
19,990
-791
-4% -$12.4K 0.01% 304
2024
Q4
$458K Buy
+20,781
New +$437K 0.01% 230

Other funds holding CLMT

GF Fund Management's CLMT Position: Q2 2026 in Review

GF Fund Management reduced its Calumet Specialty Products (CLMT) stake by 31% in Q2 2026, selling an estimated $220K and leaving 14,674 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #211.

GF Fund Management first reported a position in CLMT in Q4 2024 and has held it in 7 quarters since. The position peaked at $762K in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • GF Fund Management held 14,674 shares of Calumet Specialty Products worth $529K as of Q2 2026.
  • GF Fund Management sold 6,549 Calumet Specialty Products shares in Q2 2026, an estimated $220K.
  • Calumet Specialty Products made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #211 holding.
  • GF Fund Management first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Calumet Specialty Products position peaked at $762K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.